世界の乳がんスクリーニング検査市場は2023年に約29億3,000万米ドルと評価され、2024年から2032年の予測期間にわたって54.3%の健全なCAGRで成長すると予測されています。
乳がんスクリーニング検査は早期発見に不可欠で、症状が現れる前に病気を特定できる可能性があり、治療結果と生存率を大幅に改善します。主要なスクリーニングツールには、マンモグラフィー、臨床乳房検査、遺伝子検査などがあり、それぞれが乳がんの早期発見に役立つ独自の診断情報を提供します。乳がんに対する意識の高まりと、デジタルマンモグラフィーや3D乳房画像などのスクリーニング技術の進歩が相まって、世界市場を支えています。さらに、女性に定期的なスクリーニングを奨励する政府の取り組みや啓発キャンペーンが増えていることも、市場の成長を促進する重要な要因です。ピンクリボンキャンペーンやWHOの世界乳がんイニシアチブなどのプログラムにより、意識が大幅に向上し、乳がんスクリーニングが世界中でより利用しやすくなりました。
さらに、個別化医療への関心が高まっているため、BRCA遺伝子検査などの個別化診断ツールの需要が急増しています。遺伝子検査は、乳がんに対する感受性を特定するのに役立つだけでなく、患者と医療従事者が予防措置を講じることを可能にし、早期発見の範囲を広げます。償還状況も世界的に改善しており、特に北アメリカなどの先進地域では、いくつかのヘルスケアプランが定期的なスクリーニング費用をカバーしており、市場の成長をさらに加速させています。
市場は大きな可能性を秘めていますが、高度な診断検査に伴う高コスト、過剰診断の懸念、高濃度乳房組織の患者に対する従来のスクリーニング方法の限界など、いくつかの課題が残っています。とはいえ、新しいスクリーニング技術と診断ツールへの人工知能の統合に関する継続的な研究により、市場プレーヤーに大きな成長の機会がもたらされると期待されています。
北アメリカ地域は現在、主に医療インフラの整備、早期発見への意識の高まり、診断技術の大幅な進歩により、乳がんスクリーニング検査市場を支配しています。対照的に、アジア太平洋地域は、医療投資の増加、スクリーニング プログラムへのアクセス性の向上、中国やインドなどの国での意識向上の取り組みの拡大により、最も高い成長率を示すことが予測されています。
目次
Table of Contents
Chapter 1. Global Breast Cancer Screening Tests Market Executive Summary
1.1. Global Breast Cancer Screening Tests Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Diagnostics Test Type
1.3.2. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Breast Cancer Screening Tests Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Breast Cancer Screening Tests Market Dynamics
3.1. Market Drivers
3.1.1. Rising Awareness and Early Detection Practices
3.1.2. Technological Advancements in Breast Cancer Screening
3.1.3. Increased Adoption of Genetic Testing
3.2. Market Challenges
3.2.1. False Positives and Overdiagnosis
3.2.2. High Cost of Advanced Screening Tests
3.3. Market Opportunities
3.3.1. Expansion of Breast Cancer Screening Initiatives
3.3.2. Technological Innovations in AI-Powered Diagnostics
Chapter 4. Global Breast Cancer Screening Tests Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Breast Cancer Screening Tests Market Size & Forecast by Diagnostics Test Type (2022-2032)
5.1. Segment Dashboard
5.2. Global Breast Cancer Screening Tests Market: Diagnostics Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Blood Marker Tests
5.2.2. Imaging Test
5.2.3. Genetic Test
5.2.4. Immunohistochemistry Test
Chapter 6. Global Breast Cancer Screening Tests Market Size & Forecast by End User (2022-2032)
6.1. Segment Dashboard
6.2. Global Breast Cancer Screening Tests Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Hospitals
6.2.2. Diagnostic Centres
6.2.3. Cancer Institutes
6.2.4. Research Laboratories
Chapter 7. Global Breast Cancer Screening Tests Market Size & Forecasts by Region (2022-2032)
7.1. North America Breast Cancer Screening Tests Market
7.1.1. U.S. Market
7.1.1.1. Diagnostics Test Type Breakdown Size & Forecasts (2022-2032)
7.1.2. Canada Market
7.1.2.1. Diagnostics Test Type Breakdown Size & Forecasts (2022-2032)
7.2. Europe Breast Cancer Screening Tests Market
7.2.1. U.K. Market
7.2.2. Germany Market
7.2.3. France Market
7.2.4. Spain Market
7.2.5. Italy Market
7.2.6. Rest of Europe Market
7.3. Asia-Pacific Breast Cancer Screening Tests Market
7.3.1. China Market
7.3.2. India Market
7.3.3. Japan Market
7.3.4. Australia Market
7.3.5. South Korea Market
7.3.6. Rest of Asia Pacific Market
7.4. Latin America Breast Cancer Screening Tests Market
7.4.1. Brazil Market
7.4.2. Mexico Market
7.4.3. Rest of Latin America Market
7.5. Middle East & Africa Breast Cancer Screening Tests Market
7.5.1. Saudi Arabia Market
7.5.2. South Africa Market
7.5.3. Rest of Middle East & Africa Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. General Electric Company
8.3.2. Myriad Genetics
8.3.3. Novartis
8.3.4. AstraZeneca
8.3.5. Biocrates Life Sciences AG
8.3.6. Pfizer
8.3.7. A&G Pharmaceutical, Inc.
8.3.8. Hologic Inc.
8.3.9. Siemens Healthineers
8.3.10. Koninklijke Philips NV
8.3.11. Fujifilm Holdings
8.3.12. Metabolomic Technologies, Inc.
8.3.13. Sanofi
8.3.14. Bayer AG
8.3.15. GlaxoSmithKline plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
List of Tables
TABLE 1. Global Breast Cancer Screening Tests Market, Report Scope
TABLE 2. Global Breast Cancer Screening Tests Market Estimates & Forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Breast Cancer Screening Tests Market Estimates & Forecasts by Diagnostics Test Type 2022-2032 (USD Billion)
TABLE 4. Global Breast Cancer Screening Tests Market Estimates & Forecasts by End User 2022-2032 (USD Billion)
TABLE 5. U.S. Breast Cancer Screening Tests Market by Diagnostics Test Type (2022-2032)
TABLE 6. Canada Breast Cancer Screening Tests Market by Diagnostics Test Type (2022-2032)
TABLE 7. U.K. Breast Cancer Screening Tests Market by Diagnostics Test Type (2022-2032)
TABLE 8. Germany Breast Cancer Screening Tests Market by Diagnostics Test Type (2022-2032)
TABLE 9. China Breast Cancer Screening Tests Market by Diagnostics Test Type (2022-2032)
…
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Breast Cancer Screening Tests Market, Research Methodology
FIG 2. Global Breast Cancer Screening Tests Market, Market Estimation Techniques
FIG 3. Global Market Size Estimates & Forecast Methods
FIG 4. Global Breast Cancer Screening Tests Market, Key Trends 2023
FIG 5. Global Breast Cancer Screening Tests Market, Growth Prospects 2022-2032
FIG 6. Global Breast Cancer Screening Tests Market, Porter’s 5 Force Model
FIG 7. Global Breast Cancer Screening Tests Market, PESTEL Analysis
FIG 8. Global Breast Cancer Screening Tests Market, Value Chain Analysis
FIG 9. Global Breast Cancer Screening Tests Market by Segment, 2022 & 2032 (USD Billion)
FIG 10. North America Breast Cancer Screening Tests Market, 2022 & 2032 (USD Billion)
FIG 11. Europe Breast Cancer Screening Tests Market, 2022 & 2032 (USD Billion)
FIG 12. Asia-Pacific Breast Cancer Screening Tests Market, 2022 & 2032 (USD Billion)
FIG 13. Latin America Breast Cancer Screening Tests Market, 2022 & 2032 (USD Billion)
…
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
